ALKERMES | Ativos



Assets Alterar Data
AbbVie USD 136.17B 1B 2025-03
Acadia Pharmaceuticals USD 1.23B 93.19M 2025-06
ALKERMES USD 2.25B 170.83M 2025-06
Amgen USD 87.9B 1.47B 2025-06
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Eli Lilly USD 100.92B 11.53B 2025-06
Gilead Sciences USD 55.72B 713M 2025-06
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
J&J USD 193.67B 13.57B 2025-03
Malin Corporation EUR 198.5M 70.1M 2024-12
Merck USD 117.52B 2.4B 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Otsuka Holdings JPY 3.79T 96.25B 2025-06
Pfizer USD 206.1B 1.93B 2025-06
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06


ALKERMES Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.